Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine (Lyso-Gb3) and time to initiation of enzyme replacement therapy, an observational study

Introduction:

Methods:

Results: 

Conclusion:

Authors / corresponding author* 

JAlbinaNowak^aSarah H.Haile^bDavid C.Kasper^cThomas P.Mechtler^cAndreas J.Flammer^aPierre A.Krayenbuehl^dDaniel P.Franzen^a

University Hospital Zurich, Zurich, Switzerland

^b

University Zurich, Zurich, Switzerland

^c

ARCHIMED Life Science, Vienna, Austria

^d

Linth Hospital, Uznach, Switzerland

1